Table II.

Clinician-assessed and patient-reported chronic graft-versus-host disease assessment

	Measurement	Assessor
Skin
Erythematous rash	% BSA	C
Moveable sclerosis	% BSA	C
Nonmoveable sclerosis/fasciitis	% BSA	C
Ulcer	Largest diameter	C
Pruritus	0–10	P
Eyes
Bilateral Schirmer tear test	Mean of both eyes	C
Main ocular symptom	0–10 scale	P
Mouth
Erythema	Total score 0–15	C
Lichen planus/hyperkeratosis		C
Mucoceles		C
Oral pain/dryness/sensitivity	0–10 scale	P
Hematology
Platelet count	No. per μL	C
Eosinophils	%	C
Gastrointestinal
Upper GI symptoms	0–3	C
Esophageal symptoms	0–3	C
Diarrhea	0–3 score	C
Liver
Total serum bilirubin	mg/dL	C
ALT, alkaline phosphatase	U/L	C

Adapted from Pavletic et al.⁷⁷

ALT, Alanine aminotransferase; BSA, body surface area; C, clinician; GI, gastrointestinal; P, patient.